background
pharmacolog
inhibitor
phosphodiesteras
sildenafil
promis
candid
antioxid
therapi
result
cardiovascular
protect
addit
known
effect
cardiovascular
system
hypercholesterolemia
lead
increas
oxid
stress
dna
damag
bone
marrow
nonclass
target
organ
atherosclerosi
present
studi
evalu
oxid
stress
assess
effect
genom
instabl
cell
cycl
kinet
atherosclerot
anim
determin
sildenafil
revers
detriment
effect
bone
marrow
cell
method
experi
perform
male
wildtyp
wt
apolipoprotein
e
knockout
mice
apo
week
age
apo
mice
randomli
distribut
follow
group
sildenafiltr
mgkgday
week
n
vehicletr
n
oral
gavag
treatment
bone
marrow
cell
isol
assess
product
superoxid
anion
hydrogen
peroxid
determin
cell
cycl
kinet
evalu
presenc
micronucl
cell
result
sildenafil
treatment
reduc
cytoplasm
level
superoxid
anion
decreas
p
decreas
hydrogen
peroxid
decreas
p
moreov
observ
protect
effect
dna
bone
marrow
cell
includ
normal
cell
cycl
decreas
dna
fragment
diminish
frequenc
micronucl
cell
conclus
data
reveal
excess
product
ro
atherosclerot
mice
overcom
dna
repair
pathway
bone
marrow
cell
novelti
present
studi
administr
sildenafil
reduc
ro
baselin
level
consequ
revert
dna
damag
outcom
bone
marrow
cell
hypercholesterolemia
remain
one
import
risk
factor
cardiovascular
morbid
mortal
high
plasma
cholesterol
level
trigger
cascad
event
includ
inflamm
oxid
stress
cell
damag
particularli
cardiovascular
system
addit
previous
shown
hypercholesterolemia
increas
oxid
stress
differ
cell
type
includ
bone
marrow
mononuclear
cell
understand
mechan
underli
atherosclerosi
develop
progress
impact
cell
function
use
apolipoprotein
e
defici
apo
mice
show
high
level
plasma
cholesterol
develop
atherosclerot
lesion
resembl
human
diseas
emerg
evid
suggest
benefici
effect
phosphodiesteras
inhibit
sildenafil
cardiovascular
diseas
target
organ
howev
effect
sildenafil
oxid
dna
damag
bone
marrow
cell
apo
mice
yet
character
studi
first
work
attempt
character
antioxid
effect
sildenafil
bone
marrow
cell
mean
protect
main
sourc
adult
stem
cell
damag
reactiv
oxygen
speci
ro
studi
import
implic
cardiovascular
diseas
includ
atherosclerosi
known
risk
factor
develop
cardiac
renal
vascular
morbid
present
work
assess
oxid
stress
link
genom
instabl
cell
cycl
kinet
atherosclerot
anim
addit
evalu
abil
sildenafil
prevent
damag
incur
ro
bone
marrow
cell
knowledg
first
report
demonstr
chronic
sildenafil
administr
prevent
oxid
stress
genom
instabl
cell
cycl
arrest
bone
marrow
cell
atherosclerot
mice
experi
perform
male
wildtyp
wt
n
apolipoprotein
edefici
apo
mice
anim
bred
maintain
anim
care
facil
laboratori
translat
physiolog
feder
univers
espirito
santo
brazil
mice
hous
individu
plastic
cage
control
temperatur
humid
expos
lightdark
cycl
mice
fed
standard
chow
diet
access
water
ad
libitum
apo
mice
distribut
follow
group
n
per
group
sildenafil
pfizer
laboratori
paulo
brazil
treat
oral
gavag
mgkgday
week
sil
vehicl
salin
treat
experiment
procedur
perform
accord
guidelin
care
handl
laboratori
anim
recommend
nation
institut
health
nih
studi
protocol
previous
approv
institut
anim
care
committe
ceuauf
protocol
total
serum
cholesterol
triglycerid
blood
sampl
determin
use
commerci
colorimetr
assay
kit
bioclin
belo
horizont
brazil
bone
marrow
cell
obtain
femur
tibia
mice
euthan
sodium
thiopent
overdos
mgkg
ip
clean
soft
tissu
epiphys
remov
gain
access
marrow
caviti
whole
bone
marrow
flush
dmem
result
cell
suspens
incub
twice
lyse
buffer
min
remov
erythrocyt
cell
suspens
subsequ
centrifug
min
rpm
cell
count
assess
viabil
neubauer
chamber
sampl
consid
viabl
found
aliv
ro
analysi
perform
flow
cytometri
use
dihydroethidium
dhe
dichlorofluorescein
diacet
dcf
detect
intracellular
h
respect
previous
describ
briefli
dhe
mm
dcfda
mm
ad
cell
suspens
cell
incub
min
dark
cell
kept
ice
flow
cytometr
acquisit
event
facscanto
ii
becton
dickinson
san
juan
ca
data
analyz
use
facsdiva
softwar
becton
dickinson
express
median
fluoresc
intens
mfi
cell
cycl
distribut
bone
marrow
cell
determin
flow
cytometri
analysi
use
propidium
iodid
pi
previous
describ
briefli
bone
marrow
cell
fix
h
cold
ethanol
incub
min
stain
solut
mgml
rnase
mgml
pi
triton
determin
cell
cycl
distribut
sampl
process
triplic
event
facscanto
ii
flow
cytomet
cell
cycl
profil
determin
via
data
analysi
perform
facsdiva
softwar
data
express
percentag
cell
cell
cycl
phase
subg
g
g
g
evalu
genotox
risk
atherosclerosi
antigenotox
activ
sildenafil
mice
micronucleu
test
perform
bone
marrow
cell
experi
perform
accord
von
ledebur
schmid
briefli
bone
marrow
cell
flush
humeru
foetal
bovin
serum
centrifug
rpm
min
cell
resuspend
drop
smear
individu
glass
slide
sampl
fix
methanol
h
subsequ
stain
leishman
stain
slide
analyz
light
microscop
detect
micronuclei
young
red
blood
cell
experiment
group
number
micronucl
polychromat
erythrocyt
pce
determin
use
two
slide
per
anim
pce
per
slide
genotox
antigenotox
determin
compar
number
micronucl
pce
group
addit
cytotox
evalu
ratio
pce
normochromat
erythrocyt
pcenc
first
cell
observ
data
shown
mean
sem
normal
variabl
previous
analyz
use
kolmogorovsmirnov
test
data
exhibit
gaussian
distribut
statist
analysi
perform
use
oneway
analysi
varianc
anova
anova
show
signific
differ
tukey
test
perform
post
hoc
analysi
differ
mean
consid
signific
p
tabl
show
averag
valu
total
plasma
cholesterol
triglycerid
wt
apo
mice
treat
sildenafil
vehicl
expect
cholesterol
triglycerid
level
apo
mice
higher
respect
wt
mice
p
sildenafil
treatment
chang
valu
paramet
fig
product
determin
flow
cytometri
use
dhe
dcfda
fluoresc
dye
respect
expect
apo
mice
exhibit
markedli
augment
p
product
mfi
compar
wt
anim
mfi
increas
valu
reduc
level
compar
found
wt
control
upon
treatment
sildenafil
mfi
product
h
also
significantli
higher
apo
group
p
compar
wt
anim
mfi
reduc
upon
sildenafil
treatment
level
compar
found
wt
mice
mfi
consid
augment
ro
known
caus
damag
dna
evalu
cell
cycl
distribut
pi
stain
flow
cytometr
analysi
determin
percentag
cell
fragment
interphas
duplic
duplic
dna
figur
show
percentag
cell
differ
phase
cell
cycl
includ
subg
fig
g
g
fig
fig
g
fig
percentag
bone
marrow
cell
subg
g
g
phase
significantli
augment
apo
mice
compar
wt
anim
paramet
return
control
group
valu
apo
mice
chronic
administ
sildenafil
subg
wt
vs
apo
vs
sil
fig
g
g
wt
vs
apo
vs
sil
fig
percentag
bone
marrow
cell
g
phase
significantli
diminish
apo
mice
compar
wt
anim
chronic
administr
sildenafil
return
paramet
wt
level
vs
apo
vs
sil
fig
g
wt
vs
apo
vs
sil
fig
present
studi
micronucleu
test
perform
bone
marrow
sampl
investig
protect
effect
sildenafil
dna
apo
mice
figur
show
typic
imag
pce
nce
micronucl
pce
mnpce
bone
marrow
signific
increas
micronuclei
incid
observ
apo
mice
mnpce
compar
wt
mice
mnpce
sildenafil
treatment
mnpce
abl
reduc
frequenc
micronucl
cell
fig
addit
ratio
pcenc
reveal
atherosclerosi
per
se
yield
cytotox
effect
compar
wt
mice
wt
vs
apo
addit
sildenafil
treatment
protect
bone
marrow
cell
apo
mice
cytotox
effect
hypercholesterolemia
studi
show
first
time
chronic
inhibit
sildenafil
restor
cell
cycl
kinet
progress
prevent
genom
instabl
decreas
ro
product
bone
marrow
cell
apo
mice
previous
demonstr
link
increas
ro
product
dna
damag
bone
marrow
cell
apo
mice
also
demonstr
sildenafil
treatment
abl
reduc
dna
damag
blood
renal
liver
cell
howev
evid
sildenafil
antioxid
effect
bone
marrow
cell
consequ
dna
damag
explor
phenomenon
evalu
effect
sildenafil
antioxid
antigenotox
consequ
antimutagen
drug
bone
marrow
cell
apo
mice
atherosclerot
mice
show
higher
plasma
cholesterol
triglycerid
level
wt
mice
corrobor
recent
find
chronic
administr
sildenafil
chang
plasma
lipid
profil
atherosclerot
anim
agreement
previou
result
oxid
stress
implic
caus
factor
cardiovascular
diseas
atherosclerot
plaqu
develop
cell
accumul
high
level
ro
play
import
role
diseas
initi
progress
excess
ro
trigger
toxic
effect
damag
biomolecul
lead
cell
death
present
studi
superoxid
anion
hydrogen
peroxid
level
augment
bone
marrow
cell
apo
mice
find
agreement
tonini
et
al
like
due
hyperactiv
rosproduc
enzym
decreas
activ
rosscaveng
enzym
addit
demonstr
first
time
chronic
treatment
sildenafil
abl
restor
ro
product
baselin
level
bone
marrow
cell
apo
mice
known
sildenafil
regul
nocgmp
signal
implic
pathogenesi
atherosclerosi
taken
togeth
data
show
sildenafil
reduc
ro
product
without
modifi
lipid
profil
apo
mice
ro
wellknown
genotoxin
associ
dna
damag
cardiovascular
diseas
postul
atherosclerosi
lead
oxid
stress
could
indirectli
caus
genom
instabl
excess
ro
lead
doublestrand
dna
break
micronucleu
test
simpl
quick
techniqu
commonli
use
detect
genotox
cytotox
induc
chemic
substanc
howev
present
studi
use
micronucleu
test
investig
mutagen
effect
hypercholesterolemia
bone
marrow
cell
atherosclerot
mice
micronuclei
form
anaphas
due
mismatch
repair
doublestrand
break
common
form
oxid
damag
dna
demonstr
concurr
increas
ro
product
mnpce
frequenc
apo
mice
compar
wt
anim
taken
togeth
data
suggest
atherosclerosi
potenti
genotox
hand
anim
chronic
treat
sildenafil
exhibit
mnpce
close
control
level
suggest
sildenafil
could
antimutagen
drug
due
antioxid
activ
addit
apo
mice
show
higher
cytotox
evalu
ratio
pcenc
compar
wt
mice
suggest
hypercholesterolemia
present
cytotox
action
bone
marrow
cell
atherosclerot
mice
sildenafil
treatment
complet
abolish
toxic
result
micronucleu
test
suggest
chronic
administr
sildenafil
antigenotox
anticytotox
consequ
antimutagen
effect
due
antioxid
activ
bone
marrow
cell
atherosclerot
mice
well
known
elev
ro
level
alter
cell
cycl
progress
present
studi
found
oxid
stress
chang
cell
cycl
bone
marrow
cell
atherosclerot
mice
bone
marrow
cell
apo
mice
less
prolif
wt
mice
cell
g
g
phase
less
phase
suggest
hypercholesterolemia
induc
g
g
arrest
bone
marrow
cell
addit
percentag
bone
marrow
cell
phase
decreas
apo
mice
accompani
simultan
increas
percentag
cell
g
g
phase
suggest
inhibit
progress
phase
cell
arrest
g
g
phase
may
die
may
repair
reenter
next
phase
cell
cycl
observ
cell
subg
phase
due
dna
fragment
suggest
increas
apoptosi
atherosclerot
mice
interestingli
sildenafil
treatment
rescu
cell
g
g
growth
arrest
decreas
dna
fragment
restor
normal
cell
cycl
distribut
protect
cell
undergo
apoptosi
mammalian
cell
subject
cycl
checkpoint
allow
dna
damag
repair
slow
arrest
cell
cycl
progress
therebi
prevent
transmiss
damag
chromosom
therefor
suspect
g
g
arrest
observ
apo
mice
may
trigger
oxidativedna
damag
prevent
sildenafil
treatment
knowledg
first
use
flow
cytometri
show
chronic
sildenafil
treatment
oral
gavag
addit
vasoact
indirectli
prevent
damag
bone
marrow
cell
reduc
ro
product
genom
instabl
consequ
preserv
cell
cycl
kinet
differ
cell
type
atherosclerot
hypertens
mice
consid
bone
marrow
primari
stem
cell
sourc
adult
autolog
transplant
prefer
therapi
clinic
applic
data
provid
insight
therapeut
potenti
bone
marrow
stem
cell
patient
cardiovascular
diseas
conclus
data
reveal
excess
product
ro
atherosclerot
mice
overcom
dna
repair
pathway
bone
marrow
cell
novelti
present
studi
administr
sildenafil
reduc
ro
baselin
level
consequ
revert
dna
damag
outcom
bone
marrow
cell
note
lot
effort
discov
promis
pharmacolog
strategi
avoid
tissu
damag
induc
oxid
stress
therefor
studi
need
clear
mechan
sildenafil
act
antioxid
antigenotox
drug
